Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Captopril--an overview.

C Rosendorff

    South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
    |October 16, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Captopril effectively lowers blood pressure and treats heart failure by inhibiting angiotensin II formation. This antihypertensive drug offers benefits comparable to other treatments for essential hypertension.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers.

    Neurology·2006
    Same author

    Effects of LDL cholesterol on vascular function.

    Journal of human hypertension·2002
    Same author

    Calcium antagonists and secondary prevention of myocardial infarction; [comment].

    Lancet (London, England)·2000
    Same author

    Statins for prevention of stroke.

    Lancet (London, England)·1998
    Same author

    The renin-angiotensin system--from Tigerstedt to Goldblatt to ACE inhibition and beyond.

    The Mount Sinai journal of medicine, New York·1998
    Same author

    Vascular hypertrophy in hypertension: role of the renin-angiotensin system.

    The Mount Sinai journal of medicine, New York·1998
    Same journal

    SAMA Health Summit Abstracts.

    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2026
    Same journal

    On behalf of the South African Medical Association (SAMA), The Scientific Committee of the SAMA Health Summit, is pleased to pesent this abstract issue, showcasing the posters and oral presentations delivered at the Summit, which was held from 22-24 May 2026.

    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2026
    Same journal

    Proceedings of the 2<sup>nd</sup> Data Driven Surgery Conference (DDSC 2025).

    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2026
    Same journal

    Clinical practice guidelines for the management of fever and neutropenia in South African children and adolescents with cancer.

    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2026
    Same journal

    The changing fortunes of the District Health System in SA (1994 - 2020): A retrospective review.

    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2026
    Same journal

    Thomas Micheal Guntram Ignaz Rehle (1951 - 2025).

    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2026
    See all related articles

    Area of Science:

    • Pharmacology
    • Cardiology
    • Nephrology

    Background:

    • Captopril is an orally active antagonist of peptidyl-dipeptide carboxyhydrolase.
    • This enzyme converts angiotensin I to angiotensin II and inactivates bradykinin, impacting blood pressure regulation.

    Purpose of the Study:

    • To evaluate the efficacy and safety of captopril in treating hypertension and congestive heart failure.
    • To compare captopril's effectiveness against placebo, propranolol, and diuretics.

    Main Methods:

    • Analysis of 96 studies involving 1570 patients with essential hypertension.
    • Assessment of captopril in severe treatment-resistant hypertension and refractory congestive heart failure.
    • Review of side-effect profiles, including skin rashes, proteinuria, nephrotic syndrome, and neutropenia.

    Related Experiment Videos

    Main Results:

    • Captopril demonstrated superiority over placebo and equivalence to propranolol or diuretics for essential hypertension.
    • It showed better response than standard triple therapy in severe resistant hypertension.
    • Captopril, with digitalis and a diuretic, improved outcomes in refractory congestive heart failure.

    Conclusions:

    • Captopril is a significant antihypertensive and afterload-reducing drug.
    • Primary indications include refractory severe hypertension and congestive heart failure.
    • Potential side effects like proteinuria and neutropenia require monitoring.